Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2000 2
2005 2
2007 3
2008 2
2009 3
2010 2
2011 1
2012 1
2014 2
2015 1
2016 3
2017 2
2018 2
2019 2
2020 2
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
Long-term sexual functioning in germ-cell tumor survivors.
Chovanec M, Vasilkova L, Petrikova L, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Kalavska K, Svetlovska D, Mladosievicova B, Mardiak J, Mego M. Chovanec M, et al. Among authors: sycova mila z. BMC Cancer. 2020 Aug 20;20(1):779. doi: 10.1186/s12885-020-07301-6. BMC Cancer. 2020. PMID: 32819309 Free PMC article.
Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors.
Chovanec M, Vasilkova L, Setteyova L, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Kalavska K, Svetlovska D, Cingelova S, Mladosievicova B, Mardiak J, Mego M. Chovanec M, et al. Among authors: sycova mila z. Oncologist. 2018 May;23(5):617-623. doi: 10.1634/theoncologist.2017-0457. Epub 2018 Jan 19. Oncologist. 2018. PMID: 29352051 Free PMC article.
Are Changes in the Percentage of Specific Leukocyte Subpopulations Associated with Endogenous DNA Damage Levels in Testicular Cancer Patients?
Kalavska K, Sestakova Z, Mlcakova A, Kozics K, Gronesova P, Hurbanova L, Miskovska V, Rejlekova K, Svetlovska D, Sycova-Mila Z, Obertova J, Palacka P, Mardiak J, Chovanec M, Chovanec M, Mego M. Kalavska K, et al. Among authors: sycova mila z. Int J Mol Sci. 2021 Jul 31;22(15):8281. doi: 10.3390/ijms22158281. Int J Mol Sci. 2021. PMID: 34361047 Free PMC article.
Survival Prediction by Baseline Systemic Immune-inflammation Index (SII) and its Changes During First-line Platinum-based Treatment in a Caucasian Population of Patients With Metastatic Urothelial Carcinoma (MUC).
Palacka P, Slopovsky J, Obertova J, Chovanec M, Rejlekova K, Sycova-Mila Z, Kollarik B, Mardiak J, Mego M. Palacka P, et al. Among authors: sycova mila z. Anticancer Res. 2021 Nov;41(11):5749-5759. doi: 10.21873/anticanres.15391. Anticancer Res. 2021. PMID: 34732448
Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial.
Mego M, Rejlekova K, Svetlovska D, Miskovska V, Gillis AJM, De Angelis V, Kalavska K, Obertova J, Palacka P, Reckova M, Sycova-Mila Z, Pindak D, Chovanec M, Looijenga LHJ, Mardiak J. Mego M, et al. Among authors: sycova mila z. Eur Urol Open Sci. 2021 Sep 22;33:19-27. doi: 10.1016/j.euros.2021.09.002. eCollection 2021 Nov. Eur Urol Open Sci. 2021. PMID: 34738090 Free PMC article.
DNA damage measured in blood cells predicts overall and progression-free survival in germ cell tumour patients.
Sestakova Z, Kalavska K, Smolkova B, Miskovska V, Rejlekova K, Sycova-Mila Z, Palacka P, Obertova J, Holickova A, Hurbanova L, Jurkovicova D, Roska J, Goffa E, Svetlovska D, Chovanec M, Mardiak J, Mego M, Chovanec M. Sestakova Z, et al. Among authors: sycova mila z. Mutat Res Genet Toxicol Environ Mutagen. 2020 Jun-Jul;854-855:503200. doi: 10.1016/j.mrgentox.2020.503200. Epub 2020 May 23. Mutat Res Genet Toxicol Environ Mutagen. 2020. PMID: 32660824
Phase II study of avelumab in multiple relapsed/refractory germ cell cancer.
Mego M, Svetlovska D, Chovanec M, Rečkova M, Rejlekova K, Obertova J, Palacka P, Sycova-Mila Z, De Giorgi U, Mardiak J. Mego M, et al. Among authors: sycova mila z. Invest New Drugs. 2019 Aug;37(4):748-754. doi: 10.1007/s10637-019-00805-4. Epub 2019 Jun 1. Invest New Drugs. 2019. PMID: 31152292 Clinical Trial.
Sunitinib in patients with cisplatin-refractory germ cell tumors.
Reckova M, Mego M, Sycova-Mila Z, Obertova J, Svetlovska D, Mardiak J. Reckova M, et al. Among authors: sycova mila z. Onkologie. 2012;35(7-8):455-6. doi: 10.1159/000341079. Epub 2012 Jul 3. Onkologie. 2012. PMID: 22846980 Free article. Clinical Trial. No abstract available.
Phase II study of everolimus in refractory testicular germ cell tumors.
Mego M, Svetlovska D, Miskovska V, Obertova J, Palacka P, Rajec J, Sycova-Mila Z, Chovanec M, Rejlekova K, Zuzák P, Ondrus D, Spanik S, Reckova M, Mardiak J. Mego M, et al. Among authors: sycova mila z. Urol Oncol. 2016 Mar;34(3):122.e17-22. doi: 10.1016/j.urolonc.2015.10.010. Epub 2015 Nov 21. Urol Oncol. 2016. PMID: 26612480 Clinical Trial.
36 results